Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Saranas
AddedFeb 17, 2024
UpdatedJun 18, 2026
Saranas

Saranas

Series B

Saranas: Houston-based medical device firm, specializing in internal bleeding detection during catheterization since 2011.

HQ
Houston, TX, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded in 2011 and headquartered in Houston, Texas, Saranas is a medical device company dedicated to minimizing complications associated with interventional or surgical procedures. Its core mission is to enhance patient safety by providing innovative solutions for internal bleeding detection during catheterization. The company's flagship product, the Early Bird® Bleed Monitoring System, is designed to detect and monitor internal bleeding in real-time, thereby improving clinical outcomes and reducing procedural risks.

Saranas has garnered attention from notable investors and industry experts due to its groundbreaking technology. The Early Bird® system has been recognized for its clinical performance and has been featured in various medical literature and case studies. The company's impact is evident in its contribution to safer medical practices, potentially saving lives by enabling timely intervention during high-risk procedures.

Saranas - Similar Companies

Innovative Trauma Care logo

Innovative Trauma Care

Hemorai logo

Hemorai

hemorai.com

Sanus Solutions logo

Sanus Solutions

sanussolutions.com

Early Bird Medical logo

Early Bird Medical

earlybirdmed.com

EndoShunt Medical logo

EndoShunt Medical

endoshunt.com

Nephrosant logo

Nephrosant

Sanguis logo

Sanguis

sanguiswine.com

Bright Uro logo

Bright Uro

brighturo.com

BC3 Technologies logo

BC3 Technologies

bc3tech.com

Senseer Health logo

Senseer Health

senseer.us

Saphena Medical logo

Saphena Medical

saphenamedical.com

Emergency Medical Innovation logo

Emergency Medical Innovation

Sanovas logo

Sanovas

sanovas.com

ClearLine MD logo

ClearLine MD

Single Pass logo

Single Pass

singlepass.co

Saranas - Quick Facts

Who are Saranas' competitors?

Companies similar to Saranas include Innovative Trauma Care, Hemorai, Sanus Solutions and Early Bird Medical.

When was Saranas founded?

Saranas was founded in 2011.

Where is Saranas' headquarters located?

Saranas' headquarters is located in Houston, TX, US.

When was Saranas' last funding round?

Saranas' most recent funding round was for $12.8M (USD) in July 2021.

How much has Saranas raised to-date?

As of Jul 19, 2021, Saranas has raised a total of $29.2M (USD).

How many employees does Saranas have?

Saranas has 7 employees as of Feb 5, 2024.

Saranas - Classification

Industry
  • Hardware
Technology
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Medical Device
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified